000 01630 a2200457 4500
005 20250516173803.0
264 0 _c20150409
008 201504s 0 0 eng d
022 _a1099-1263
024 7 _a10.1002/jat.2928
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWang, Si
245 0 0 _aTowards an integrated in vitro strategy for estrogenicity testing.
_h[electronic resource]
260 _bJournal of applied toxicology : JAT
_cSep 2014
300 _a1031-40 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimal Testing Alternatives
650 0 4 _aBiological Assay
_xmethods
650 0 4 _aCarrier Proteins
_xantagonists & inhibitors
650 0 4 _aCell Line, Tumor
650 0 4 _aCell Proliferation
_xdrug effects
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aEndocrine Disruptors
_xtoxicity
650 0 4 _aEndpoint Determination
650 0 4 _aEstrogen Receptor alpha
_xgenetics
650 0 4 _aEstrogens
_xpharmacology
650 0 4 _aGenes, Reporter
650 0 4 _aHumans
650 0 4 _aMCF-7 Cells
650 0 4 _aNuclear Proteins
_xantagonists & inhibitors
650 0 4 _aRNA-Binding Proteins
650 0 4 _aTranscriptional Activation
700 1 _aAarts, Jac M M J G
700 1 _ade Haan, Laura H J
700 1 _aArgyriou, Dimitrios
700 1 _aPeijnenburg, Ad A C M
700 1 _aRietjens, Ivonne M C M
700 1 _aBovee, Toine F H
773 0 _tJournal of applied toxicology : JAT
_gvol. 34
_gno. 9
_gp. 1031-40
856 4 0 _uhttps://doi.org/10.1002/jat.2928
_zAvailable from publisher's website
999 _c23160689
_d23160689